Phase 2 Study of Postoperative Three-dimensional Conformal Radiation Therapy/Intensive Modulated Radiation Therapy in Hepatocellular Carcinoma: a Single Center Prospective Study
Patients with risk factors of recurrence receive postoperative radiotherapy using intensive
modulated radiation therapy (IMRT) or three-dimensional conformal radiation therapy (3DCRT).
The clinical target volume includes tumor bed. The dose will be 50-60Gy/25-30f. Overall
survival, local-recurrence free survival, disease free survival and toxicity need be
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
the rate of overall survival for 3 year
China: Ethics Committee